Pitt-developed drug works against 'superbug' biofilms and respiratory virus

A potential drug therapy developed at the University of Pittsburgh Center for Vaccine Research (CVR) has proven effective against tough bacterial biofilms and a deadly respiratory virus simultaneously. The drug outperforms traditional therapies in the laboratory setting.

Read the whole article on Physorg

More from Physorg